. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci. 2009 Aug 15;283(1-2):199-206. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. This paper advances what is known about the ApoE-mitochondria nexus. It provides mechanistic insights potentially relevant to Alzheimer disease. It is worth the read.

  2. The authors in this paper show that acetyl-L-carnitine and R-α-lipoic acids serve as effective antioxidants that potentially reverse the human ApoE4 allele induced age-dependent pathology in AD and other age-related diseases. ApoE4 transgenic mice closely resemble AD cases, and by comparing cerebral blood flow in wild-type and ApoE4 transgenic mice, the authors clearly paved the way for developing potential therapeutics for ApoE4 allele-related AD.

  3. This paper provides a new view that is potentially relevant to Alzheimer disease pathogenesis. It is very interesting.

This paper appears in the following:

News

  1. Top AD Trends of 2009